We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Flonase Indirect Purchasers Sue SmithKline Beecham

Law360 (August 22, 2008, 12:00 AM EDT) -- Legal problems continue to stack up against SmithKline Beecham Corp., which faces another proposed class action for allegedly stalling the approval of a generic version of Flonase, the drugmaker's blockbuster nasal allergy medication.

The lawsuit, filed by Alabama-based AF Of L-AGC Building Trades Welfare Plan in the U.S. District Court for the Eastern District of Pennsylvania on Thursday, follows the filing of a similar suit by the IBEW–NECA Local 505 Health & Welfare Plan last month.

The latest proposed class action of indirect purchasers of Flonase...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.